These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 24951363)

  • 1. Toward a better follow-up of ovarian recovery in young women after chemotherapy with a hypersensitive antimüllerian hormone assay.
    Decanter C; Peigne M; Mailliez A; Morschhauser F; Dassonneville A; Dewailly D; Pigny P
    Fertil Steril; 2014 Aug; 102(2):483-7. PubMed ID: 24951363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can highly sensitive antimüllerian hormone testing predict failed response to ovarian stimulation?
    Burks HR; Ross L; Opper N; Paulson E; Stanczyk FZ; Chung K
    Fertil Steril; 2015 Sep; 104(3):643-8. PubMed ID: 26158904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of the Ultrasensitive Anti-Müllerian Hormone Assay for Predicting True Ovarian Reserve.
    Iwase A; Osuka S; Nakamura T; Kato N; Takikawa S; Goto M; Kikkawa F
    Reprod Sci; 2016 Jun; 23(6):756-60. PubMed ID: 26614267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High frequency of discordance between antimüllerian hormone and follicle-stimulating hormone levels in serum from estradiol-confirmed days 2 to 4 of the menstrual cycle from 5,354 women in U.S. fertility centers.
    Leader B; Hegde A; Baca Q; Stone K; Lannon B; Seifer DB; Broekmans F; Baker VL
    Fertil Steril; 2012 Oct; 98(4):1037-42. PubMed ID: 22771028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimüllerian hormone as a measure of reproductive function in female childhood cancer survivors.
    Lunsford AJ; Whelan K; McCormick K; McLaren JF
    Fertil Steril; 2014 Jan; 101(1):227-31. PubMed ID: 24083876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Undetectable antimüllerian hormone levels and recovery of chemotherapy-induced ovarian failure in women with breast cancer on an oral aromatase inhibitor.
    Dieudonné AS; Vandenberghe J; Geerts I; Billen J; Paridaens R; Wildiers H; Neven P
    Menopause; 2011 Jul; 18(7):821-4. PubMed ID: 21326118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of breast cancer chemotherapy on ovarian reserve: a prospective observational analysis by menstrual history and ovarian reserve markers.
    Reh A; Oktem O; Oktay K
    Fertil Steril; 2008 Nov; 90(5):1635-9. PubMed ID: 18166178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol.
    Hazout A; Bouchard P; Seifer DB; Aussage P; Junca AM; Cohen-Bacrie P
    Fertil Steril; 2004 Nov; 82(5):1323-9. PubMed ID: 15533354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of serum antimüllerian hormone in women approaching menopause using sensitive antimüllerian hormone enzyme-linked immunosorbent assays.
    Robertson DM; Kumar A; Kalra B; Shah S; Pruysers E; Vanden Brink H; Chizen D; Visser JA; Themmen AP; Baerwald A
    Menopause; 2014 Dec; 21(12):1277-86. PubMed ID: 24781853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretreatment anti-Müllerian hormone predicts for loss of ovarian function after chemotherapy for early breast cancer.
    Anderson RA; Rosendahl M; Kelsey TW; Cameron DA
    Eur J Cancer; 2013 Nov; 49(16):3404-11. PubMed ID: 23968732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single-centre evaluation of two new anti-Mullerian hormone assays and comparison with the current clinical standard assay.
    Welsh P; Smith K; Nelson SM
    Hum Reprod; 2014 May; 29(5):1035-41. PubMed ID: 24578473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age at menarche: a predictor of diminished ovarian function?
    Weghofer A; Kim A; Barad DH; Gleicher N
    Fertil Steril; 2013 Oct; 100(4):1039-43. PubMed ID: 23809497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimüllerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis patients.
    Arce JC; La Marca A; Mirner Klein B; Nyboe Andersen A; Fleming R
    Fertil Steril; 2013 May; 99(6):1644-53. PubMed ID: 23394782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does the time interval between antimüllerian hormone serum sampling and initiation of ovarian stimulation affect its predictive ability in in vitro fertilization-intracytoplasmic sperm injection cycles with a gonadotropin-releasing hormone antagonist? A retrospective single-center study.
    Polyzos NP; Nelson SM; Stoop D; Nwoye M; Humaidan P; Anckaert E; Devroey P; Tournaye H
    Fertil Steril; 2013 Aug; 100(2):438-44. PubMed ID: 23602319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amenorrhea secondary to a vismodegib-induced blockade of follicle-stimulating hormone-receptor activation.
    Strasswimmer J; Latimer B; Ory S
    Fertil Steril; 2014 Aug; 102(2):555-7. PubMed ID: 24890268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variation in antimüllerian hormone concentration during the menstrual cycle may change the clinical classification of the ovarian response.
    Hadlow N; Longhurst K; McClements A; Natalwala J; Brown SJ; Matson PL
    Fertil Steril; 2013 May; 99(6):1791-7. PubMed ID: 23433830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-Müllerian hormone as a marker of ovarian reserve following chemotherapy in patients with gestational trophoblastic neoplasia.
    Iwase A; Sugita A; Hirokawa W; Goto M; Yamamoto E; Takikawa S; Nakahara T; Nakamura T; Kondo M; Kikkawa F
    Eur J Obstet Gynecol Reprod Biol; 2013 Apr; 167(2):194-8. PubMed ID: 23274042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzyme-linked immunosorbent assay measurements of antimüllerian hormone (AMH) in human blood are a composite of the uncleaved and bioactive cleaved forms of AMH.
    Pankhurst MW; Chong YH; McLennan IS
    Fertil Steril; 2014 Mar; 101(3):846-50. PubMed ID: 24424371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modification of the Beckman-Coulter second-generation enzyme-linked immunosorbent assay protocol improves the reliability of serum antimüllerian hormone measurement.
    Craciunas L; Roberts SA; Yates AP; Smith A; Fitzgerald C; Pemberton PW
    Fertil Steril; 2015 Feb; 103(2):554-59.e1. PubMed ID: 25487749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimüllerian hormone levels decrease in female-to-male transsexuals using testosterone as cross-sex therapy.
    Caanen MR; Soleman RS; Kuijper EA; Kreukels BP; De Roo C; Tilleman K; De Sutter P; van Trotsenburg MA; Broekmans FJ; Lambalk CB
    Fertil Steril; 2015 May; 103(5):1340-5. PubMed ID: 25772768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.